Literature DB >> 9351107

Cyclosporine-related reversible posterior leukoencephalopathy: MRI.

J M Jarosz1, D C Howlett, T C Cox, J B Bingham.   

Abstract

Three patients aged 48, 11 and 40 years, two of whom were recent recipients of renal transplants and one of a bone marrow transplant, developed seizures, with cortical blindness in two cases. All were immunosuppressed with cyclosporine and were hypertensive at the onset of symptoms. MRI showed predominantly posterior signal changes in all three cases. The abnormalities were more conspicuous on fast FLAIR images than on conventional T2-weighted spin-echo images.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351107     DOI: 10.1007/s002340050492

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  12 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  Post-transplant neurotoxicity: what role do calcineurin inhibitors actually play?

Authors:  Evelyn M Sklar
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

Review 3.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

4.  PRES (posterior reversible encephalopathy syndrome), a rare complication of tacrolimus therapy.

Authors:  P Hodnett; J Coyle; K O'Regan; M M Maher; N Fanning
Journal:  Emerg Radiol       Date:  2008-12-19

5.  Brain MR imaging abnormalities in kidney transplant recipients.

Authors:  Nada Besenski; Zoran Rumboldt; Osemwegie Emovon; Joyce Nicholas; Sunil Kini; Jovan Milutinovic; Milos N Budisavljevic
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

6.  Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.

Authors:  A Ozkan; B Hakyemez; F Ozkalemkas; R Ali; V Ozkocaman; T Ozcelik; O Taskapilioglu; Y Altundal; A Tunali
Journal:  Neuroradiology       Date:  2006-09-16       Impact factor: 2.804

Review 7.  Posterior leukoencephalopathy syndrome.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

8.  Uremic encephalopathy: A definite diagnosis by magnetic resonance imaging?

Authors:  Farzad Sina; Darya Najafi; Alireza Aziz-Ahari; Elham Shahraki; Tahere Zarouk Ahimahalle; Zeinab Namjoo; Sajad Hassanzadeh
Journal:  Eur J Transl Myol       Date:  2022-08-12

9.  Reversible posterior leukoencephalopathy syndrome in a child with cerebral X-linked adrenoleukodystrophy treated with cyclosporine after bone marrow transplantation.

Authors:  A K J Chan; R Bhargava; S Desai; A Joffe
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  Treatment of myasthenia gravis based on its immunopathogenesis.

Authors:  Jee Young Kim; Kee Duk Park; David P Richman
Journal:  J Clin Neurol       Date:  2011-12-29       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.